OncoMatch/Clinical Trials/NCT05500391
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Is NCT05500391 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for stage i testicular seminoma.
This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).
Check if I qualifyExtracted eligibility criteria
Cancer type
Testicular Germ Cell Tumor
Gastrointestinal Stromal Tumor
Glioblastoma
Neuroendocrine Tumor
Disease stage
Required: Stage I
Grade: low grade
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify